Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

EMBO Journal

Volumn 18, Issue 11, 1999, Pages 3064-3073

  Gires, Olivier ^a,c   Kohlhuber, Franz ^a,b   Kilger, Ellen ^a,c   Baumann, Matthias ^a,c   Kieser, Arnd ^a,c   Kaiser, Christian ^a,c   Zeidler, Reinhard ^a,d   Scheffer, Beatrix ^a,b   Ueffing, Marius ^a,b   Hammerschmidt, Wolfgang ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Department of Gene Vectors ^*  (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

B lymphocyte; EBV; JAK3; LMP1; STAT protein

Indexed keywords

LATENT MEMBRANE PROTEIN 1; PROLINE; PROTEIN KINASE; REPETITIVE DNA; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL IMMORTALIZATION; CHIMERA; CONTROLLED STUDY; CROSS LINKING; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE LOCUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; CELL LINE; CONSENSUS SEQUENCE; DNA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HERPESVIRUS 4, HUMAN; HUMANS; JANUS KINASE 3; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOTYROSINE; PROLINE; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE DELETION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

DNA VIRUSES; HUMAN HERPESVIRUS 4; JANUS;

EID: 0033153426     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.11.3064     Document Type: Article

References (59)

1. Baichwal, V.R. and Sugden, B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene, 2, 461-467.
2. Briscoe, J., Kohlhuber, F. and Müller, M. (1996) JAKs and STATs branch out. Trends Cell Biol., 6, 336-340.
3. Catlett-Falcone, R. et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105-115.
4. Cohen, J.I., Wang, F. and Kieff, E. (1991) Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol., 65, 2545-2554.
5. Darnell, J.E. (1997) STATs and gene regulation. Science, 277, 1630-1635.
6. Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R. and Hammerschmidt, W. (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl Acad. Sci. USA, 95, 8245-8250.
7. Delecluse, H.-J., Pich, D., Hilsendegen, T., Baum, C. and Hammerschmidt, W. (1999) A first generation packaging cell line for Epstein-Barr derived vectors. Proc. Natl Acad. Sci. USA, in press.
8. Devergne, O., Hatzivassiliou, E., Izumi, K.M., Kaye, K.M., Kleijnen, M.F., Kieff, E. and Mosialos, G. (1996) Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol., 16, 7098-7108.
9. Eliopoulos, A.G. and Rickinson, A.B. (1998) LMP1 masquerades as an active receptor. Curr. Biol., 8, R196-R198.
10. Eliopoulos, A.G. and Young, L.S. (1998) Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene, 16, 1731-1742.
11. Eliopoulos, A.G., Stack, M., Dawson, C.W., Kaye, K.M., Hodgkin, L., Sihota, S., Rowe, M. and Young, L.S. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene, 14, 2899-2916.
12. Farrell, P.J. (1995) Epstein-Barr virus immortalizing genes. Trends Microbiol., 3, 105-109.
13. Floettmann, J.E. and Rowe, M. (1997) Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation. Oncogene, 15, 1851-1858.
14. Galibert, L., Burdin, N., de Saint-Vis, B., Garrone, P., Van Kooten, C., Banchereau, J. and Rousset, F. (1996) CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med., 183, 77-85.
15. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D. and Hammerschmidt, W. (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J., 16, 6131-6140.
16. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-74.
17. Hammarskjold, M.L. and Simurda, M.C. (1992) Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol., 66, 6496-6501.
18. Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, 340, 393-397.
19. Hanissian, S.H. and Geha, R.S. (1997) Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity, 6, 379-387.
20. Hatzivassiliou, E., Miller, W.E., Raab-Traub, N., Kieff, E. and Mosialos, G. (1998) A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-κB and stress-activated protein kinase. J. Immunol., 160, 1116-1121.
21. Huen, D.S., Henderson, S.A., Croom-Carter, D. and Rowe, M. (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogens, 10, 549-560.
22. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K. and Silvennoinen, O. (1995) Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol., 13, 369-398.
23. Ivashkiv, L.B. (1995) Cytokines and STATs: how can signals achieve specificity? Immunity, 3, 1-4.
24. Izumi, K.M. and Kieff, E.D. (1997) The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl Acad. Sci. USA, 94, 12592-12597.
25. Izumi, K.M., Kaye, K.M. and Kieff, E.D. (1997) The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 94, 1447-1452.
26. Karras, J.G., Wang, Z., Huo, L., Frank, D.A. and Rothstein, T.L. (1997) Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol., 159, 4350-4355.
27. Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J.N. and Taniguchi, T. (1995) Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl Acad. Sci. USA, 92, 8724-8728.
28. Kaye, K.M., Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
29. Kaye, K.M., Izumi, K.M., Mosialos, G. and Kieff, E. (1995) The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J. Virol., 69, 675-683.
30. Kieff, E. (1996) Epstein-Barr virus and its replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Monath, T.P., Melnick, J.L., Roizman, B. and Straus, S.E. (eds), Virology. 3rd edn. Lippincott-Raven Publishers, Philadelphia, PA, pp. 2343-2396.
31. Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. and Hammerschmidt, W. (1997) Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J., 16, 6478-6485.
32. Kieser, A., Kaiser, C. and Hammerschmidt, W. (1999) LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. EMBO J., 18, 2511-2521.
33. Kilger, E., Kieser, A., Baumann, M. and Hammerschmidt, W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J., 17, 1700-1709.
34. Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F. and Dixit, V.M. (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem., 267, 24157-24160.
35. Leonard, W. and O'Shea, J. (1998) JAKs and STATs: Biological Implications. Annu. Rev. Immunol., 16, 293-322.
36. Liebowitz, D., Wang, D. and Kieff, E. (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol., 58, 233-237.
37. Macchi, P. et al. (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 377, 65-68.
38. Miller, W.E., Mosialos, G., Kieff, E. and Raab-Traub, N. (1997) Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB activation. J. Virol., 71, 586-594.
39. Mitchell, T. and Sugden, B. (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol., 69, 2968-2976.
40. Moorthy, R.K. and Thorley-Lawson, D.A. (1993) All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol., 67, 1638-1646.
41. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
42. Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T. and Kishimoto, T. (1991) Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl Acad. Sci . USA, 88, 11349-11353.
43. Murata, T. and Puri, R.K. (1997) Comparison of IL-13-and IL-4-induced signaling in EBV-immortalized human B cells. Cell. Immunol., 175, 33-40.
44. Rodriguez Tarduchy, G., Collins, M. and Lopez Rivas, A. (1990) Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J., 9, 2997-3002.
45. Russell, S.M. et al. (1995) Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development. Science, 270, 797-800.
46. Sadowski, H.B., Shuai, K., Darnell, J.E., Jr and Gilman, M.Z. (1993) A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science, 261, 1739-1744.
47. Sandberg, M., Hammerschmidt, W. and Sugden, B. (1997) Characterization of LMP-1's association with TRAF1, TRAF2 and TRAF3. J. Virol., 71, 4649-4656.
48. Schindler, C., Shuai, K., Prezioso, V.R. and Darnell, J.E.,Jr (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science, 257, 809-813.
49. Silvennoinen, O., Ihle, J.N., Schlessinger, J. and Levy, D.E. (1993) Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature, 366, 583-585.
50. Tomkinson, B., Robertson, E. and Kieff, E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67, 2014-2025.
51. Tortolani, P.J. et al. (1995) Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J. Immunol., 155, 5220-5226.
52. Tosato, G., Tanner, J., Jones, K.D., Revel, M. and Pike, S.E. (1990) Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol., 64, 3033-3041.
53. Wang, D., Liebowitz, D. and Kieff, E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
54. Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A. and Kieff, E. (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol., 64, 2309-2318.
55. Weber-Nordt, R.M., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R. and Finke, J. (1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88, 809-816.
56. Witthuhn, B.A., Silvennoinen, O., Miura, O., Lai, K.S., Cwik, C., Liu, E.T. and Ihle, J.N. (1994) Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature, 370, 153-157.
57. Xu, X., Kang, S.H., Heidenreich, O., Okerholm, M., O'Shea, J.J. and Nerenberg, M.I. (1995) Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Invest., 96, 1548-1555.
58. Yates, J.L., Warren, N. and Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature, 313, 812-815.
59. Zimber-Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., Van Kooten, C., Banchereau, J., Bornkamm, G.W. and Hammerschmidt, W. (1996) Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B-cells but both it and activated CD40 can prolong their survival. EMBO J., 15, 7070-7078.